Published in Vaccine Weekly, September 26th, 2007
"In contrast, the absence of endogenous IL-12/IL-23 or IL-4 had little impact...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.